Clark George C.
Insider CIK 1878290 · BHVN VP, Chief Accounting Officer · BHVN VP, Chief Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BHVN Biohaven Ltd. | A Award deriv | 2026-02-27 | 2026-03-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2026-01-05 | 2026-01-07 | 2,500 | — | $0 | 5,000 | SEC↗ |
| BHVN Biohaven Ltd. | F Tax w/h | 2026-01-05 | 2026-01-07 | 1,117 | $9.93 | $11.1K | 66,978 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2026-01-05 | 2026-01-07 | 2,500 | — | $0 | 68,095 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2025-11-17 | 2025-11-18 | 17,000 | $8.52 | $144.8K | 20,000 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2025-01-05 | 2025-01-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2025-01-05 | 2025-01-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2025-01-05 | 2025-01-07 | 2,500 | — | $0 | 7,500 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2025-01-05 | 2025-01-07 | 2,500 | — | $0 | 66,168 | SEC↗ |
| BHVN Biohaven Ltd. | F Tax w/h | 2025-01-05 | 2025-01-07 | 1,117 | $38.64 | $43.2K | 65,051 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2024-01-02 | 2024-01-04 | 27,500 | — | $0 | 27,500 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2023-11-02 | 2023-11-06 | 22,500 | — | $0 | 22,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 9,225 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 960 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 1,915 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 2,250 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 4,602 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 2,398 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 10,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 1,250 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 775 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 1,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 1,750 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 15,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 1,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 3,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer | 2022-10-03 | 2022-10-03 | 4,292 | $148.50 | $637.4K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-05-10 | 2022-05-12 | 2,250 | — | $0 | 2,250 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2022-05-10 | 2022-05-12 | 4,200 | $141.50 | $594.3K | 4,065 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-05-10 | 2022-05-12 | 2,250 | $53.76 | $121.0K | 8,265 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-19 | 2022-01-24 | 1,920 | — | $0 | 2,875 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-19 | 2022-01-24 | 3,750 | — | $0 | 4,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2022-01-19 | 2022-01-24 | 3,196 | $114.93 | $367.3K | 12,194 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2022-01-19 | 2022-01-24 | 3,520 | $119.37 | $420.2K | 6,015 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-19 | 2022-01-24 | 3,750 | $53.76 | $201.6K | 13,470 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2022-01-19 | 2022-01-24 | 2,159 | $116.02 | $250.5K | 10,035 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2022-01-19 | 2022-01-24 | 500 | $118.05 | $59.0K | 9,535 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-19 | 2022-01-24 | 1,920 | $32.42 | $62.2K | 15,390 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-10 | 2022-01-12 | 1,000 | — | $0 | 1,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2022-01-10 | 2022-01-12 | 464 | $128.87 | $59.8K | 9,720 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-10 | 2022-01-12 | 1,000 | — | $0 | 10,184 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2022-01-07 | 2022-01-07 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-07 | 2022-01-07 | 1,000 | — | $0 | 4,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2022-01-07 | 2022-01-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-07 | 2022-01-07 | 1,000 | — | $0 | 9,706 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2022-01-07 | 2022-01-07 | 522 | $128.87 | $67.3K | 9,184 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-06 | 2022-01-07 | 875 | — | $0 | 1,750 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2022-01-06 | 2022-01-07 | 409 | $123.86 | $50.7K | 8,706 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-06 | 2022-01-07 | 875 | — | $0 | 9,115 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2021-12-20 | 2021-12-22 | 1,915 | $123.84 | $237.2K | 8,240 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-11-26 | 2021-11-26 | 5,000 | — | $0 | 15,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2021-11-26 | 2021-11-26 | 2,318 | $115.55 | $267.8K | 10,155 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-11-26 | 2021-11-26 | 5,000 | — | $0 | 12,473 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-11-23 | 2021-11-26 | 1,915 | — | $0 | 4,795 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-11-23 | 2021-11-26 | 1,915 | $32.42 | $62.1K | 7,473 | SEC↗ |